In these studies, involving about 1600 patients, analyses of patient diaries showed no effect of sildenafil on rates of attempted intercourse (about 2 per week), but there was clear treatment-related improvement in sexual function: per patient weekly success rates averaged 1.3 on 50-100 mg of sildenafil tablets vs 0.4 on placebo; similarly, group mean success rates (total successes divided by total attempts) were about 66% on sildenafil vs about 20% on placebo.During 3 to 6 months of double-blind treatment or longer-term (1 year), open-label studies, few patients withdrew from active treatment for any reason, including lack of effectiveness. At the end of the long-term study, 88% of patients reported that sildenafil improved their erections.Men with untreated ED had relatively low baseline scores for all aspects of sexual function measured (again using a 5-point scale) in the IIEF. Sildenafil improved these aspects of sexual function: frequency, firmness and maintenance of erections; frequency of orgasm; frequency and level of desire; frequency, satisfaction and enjoyment of intercourse; and overall relationship satisfaction.One randomized, double-blind, flexible-dose, placebo-controlled study included only patients with erectile dysfunction attributed to complications of diabetes mellitus (n=268). As in the other titration studies, patients were started on 50 mg and allowed to adjust the dose up to 100 mg or down to 25 mg of sildenafil tablets; all patients, however, were receiving 50 mg or 100 mg at the end of the study. There were highly statistically significant improvements on the two principal IIEF questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) on sildenafil compared to placebo. On a global improvement question, 57% of sildenafil patients reported improved erections versus 10% on placebo. Diary data indicated that on sildenafil, 48% of intercourse attempts were successful versus 12% on placebo.One randomized, double-blind, placebo-controlled, crossover, flexible-dose (up to 100 mg) study of patients with erectile dysfunction resulting from spinal cord injury (n=178) was conducted. The changes from baseline in scoring on the two end point questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) were highly statistically significantly in favor of sildenafil.

4. Technical Product Specification Table

The safety and efficacy of sildenafil tablets with other PDE5 inhibitors, including REVATIO, have not been studied [see Warnings and Precautions (5.7)].Sexually Transmitted DiseaseThe use of sildenafil tablets offers no protection against sexually transmitted diseases. Counseling of patients about the protective measures necessary to guard against sexually transmitted diseases, including the Human Immunodeficiency Virus (HIV), may be considered [see Warnings and Precautions (5.9)].Manufactured for :Macleods Pharma USA, Inc.Princeton, NJ 08540Manufactured by:Macleods Pharmaceuticals Ltd.At Oxalis LabsBaddi, Himachal Pradesh, INDIARevised: July 2025 Advise the patient to read the FDA-approved patient labeling (Patient Information) Physicians should discuss with patients the contraindication of sildenafil tablets with regular and/or intermittent use of nitric oxide donors, such as organic nitrates or organic nitrites in any form [see Contraindications (4.1)].

Related treatment guides

Vardenafil (Levitra) or Avanafil (Stendra)

On a global improvement question, 83% of patients reported improved erections on sildenafil versus 12% on placebo. Diary data indicated that on sildenafil, 59% of attempts at sexual intercourse were successful compared to 13% on placebo.Across all trials, sildenafil improved the erections of 43% of radical prostatectomy patients compared to 15% on placebo.Subgroup analyses of responses to a global improvement question in patients with psychogenic etiology in two fixed-dose studies (total n=179) and two titration studies (total n=149) showed 84% of sildenafil patients reported improvement in erections compared with 26% of placebo. Diary data in two of the studies (n=178) showed rates of successful intercourse per attempt of 70% for sildenafil and 29% for placebo.Efficacy Results in Subpopulations in Controlled Clinical StudiesA review of population subgroups demonstrated efficacy regardless of baseline severity, etiology, race and age.Sildenafil was effective in a broad range of ED patients, including those with a history of coronary artery disease, hypertension, other cardiac disease, peripheral vascular disease, diabetes mellitus, depression, coronary artery bypass graft (CABG), radical prostatectomy, transurethral resection of the prostate (TURP) and spinal cord injury, and in patients taking antidepressants/antipsychotics and anti-hypertensives/diuretics. In clinical studies, sildenafil was assessed for its effect on the ability of men with erectile dysfunction (ED) to engage in sexual activity and in many cases specifically on the ability to achieve and maintain an erection sufficient for satisfactory sexual activity. The studies that established benefit demonstrated improvements in success rates for sexual intercourse compared with placebo.

In India, sildenafil 50 mg comes in tablet form with film coating.
It can be purchased with or without a prescription depending on local laws.
Always check the expiry date before taking any medication.
The pill should be taken with water, with or without food.
Combining sildenafil with high-fat meals may delay absorption.
Some users experience facial flushing after dosage.
Use caution and seek medical care if chest pain occurs.
Avoid grapefruit or grapefruit juice as it may interfere with sildenafil.
Regular exercise and a balanced diet support sexual health.

Effect of Sildenafil tablets and Placebo on Maintenance of sildenafil generic Erection by Baseline Score.

Product	Dosage	Quantity + Bonus	Price
Viagra Generic	25mg	60 + 4 Pills	71.99€ 68.56€
Kamagra Polo	100mg	120 + 6 Pills	327.15€ 311.57€
Viagra Generic	200mg	180 + 10 Pills	277.56€ 264.34€
Kamagra Oral Jelly	100mg	21 Sachets	95.92€ 91.35€
Viagra Generic	150mg	20 Pills	55.02€ 52.40€
Kamagra Oral Jelly	100mg	10 Sachets	54.55€ 51.95€
Viagra Generic	50mg	120 + 6 Pills	129.64€ 123.47€
Kamagra	100mg	84 + 6 Pills	264.44€ 251.85€
Viagra Generic	200mg	270 + 10 Pills	379.76€ 361.68€
Viagra Generic	50mg	360 + 10 Pills	225.33€ 214.60€
Kamagra Soft Tabs	100mg	60 + 4 Pills	180.59€ 171.99€
Kamagra Soft Tabs	100mg	180 + 8 Pills	425.45€ 405.19€
Viagra Generic	200mg	90 + 6 Pills	170.79€ 162.66€
Viagra Generic	25mg	20 Pills	37.74€ 35.94€
Kamagra	100mg	180 + 6 Pills	436.79€ 415.99€

Percentage of Patients Reporting an Improvement in Erections. Across all trials, sildenafil improved the erections of 43% of radical prostatectomy patients compared to 15% on placebo.

Introduction: Sildenafil Citrate Sublingual Tablets 50mg and Its Global Demand

How are Sildenafil Citrate Tablets used?

6. What are common side-effects?

16 HOW SUPPLIED/STORAGE AND HANDLING Sildenafil tablets, USP is supplied as white to off-white, film-coated, diamond-shaped tablets containing sildenafil citrate, USP equivalent to the nominally indicated amount of sildenafil and are debossed with ‘CL35’, ‘CL36’ and ‘CL37’ on one side for 25 mg, 50 mg and 100 mg respectively and plain on the other side.Recommended Storage: Store at 20° to 25°C (68° to 77° F); excursions permitted to 15° to 30° C (59° to 86° F) [see USP Controlled Room Temperature]. Sildenafil tablets, USP is supplied as white to off-white, film-coated, diamond-shaped tablets containing sildenafil citrate, USP equivalent to the nominally indicated amount of sildenafil and are debossed with ‘CL35’, ‘CL36’ and ‘CL37’ on one side for 25 mg, 50 mg and 100 mg respectively and plain on the other side. Recommended Storage: Store at 20° to 25°C (68° to 77° F); excursions permitted to 15° to 30° C (59° to 86° F) [see USP Controlled Room Temperature]. 17 PATIENT COUNSELING INFORMATION Advise the patient to read the FDA-approved patient labeling (Patient Information)NitratesPhysicians should discuss with patients the contraindication of sildenafil tablets with regular and/or intermittent use of nitric oxide donors, such as organic nitrates or organic nitrites in any form [see Contraindications (4.1)].Guanylate Cyclase (GC) StimulatorsPhysicians should discuss with patients the contraindication of sildenafil tablets with use of guanylate cyclase stimulators such as riociguat [see Contraindications (4.3)].Concomitant Use with Drugs Which Lower Blood PressurePhysicians should advise patients of the potential for sildenafil tablets to augment the blood pressure lowering effect of alpha-blockers and anti-hypertensive medications.

Storage Condition	Details	Temperature Range	Light & Moisture Protection	Shelf Life
Ideal Storage	Cool, dry place, away from children	15-30°C	Keep in original container	2-3 years
Exposure to Light	Avoid direct sunlight	N/A	Yes	Use before expiry date
Humidity considerations	Keep away from humid environments	N/A	Yes	Maintain shelf life

Concomitant administration of sildenafil tablets and an alphablocker may lead to symptomatic hypotension in some patients.

Sildenafil Dosage for Erectile Dysfunction

Across all trials, sildenafil improved the erections of 43% of radical prostatectomy patients compared to 15% on placebo. 16 HOW SUPPLIED/STORAGE AND HANDLING Sildenafil tablets, USP is supplied as white to off-white, film-coated, diamond-shaped tablets containing sildenafil citrate, USP equivalent to the nominally indicated amount of sildenafil and are debossed with ‘CL35’, ‘CL36’ and ‘CL37’ on one side for 25 mg, 50 mg and 100 mg respectively and plain on the other side.Recommended Storage: Store at 20° to 25°C (68° to 77° F); excursions permitted to 15° to 30° C (59° to 86° F) [see USP Controlled Room Temperature]. Sildenafil tablets, USP is supplied as white to off-white, film-coated, diamond-shaped tablets containing sildenafil citrate, USP equivalent to the nominally indicated amount of sildenafil and are debossed with ‘CL35’, ‘CL36’ and ‘CL37’ on one side for 25 mg, 50 mg and 100 mg respectively and plain on the other side. Recommended Storage: Store at 20° to 25°C (68° to 77° F); excursions permitted to 15° to 30° C (59° to 86° F) [see USP Controlled Room Temperature]. 17 PATIENT COUNSELING INFORMATION Advise the patient to read the FDA-approved patient labeling (Patient Information)NitratesPhysicians should discuss with patients the contraindication of sildenafil tablets with regular and/or intermittent use of nitric oxide donors, such as organic nitrates or organic nitrites in any form [see Contraindications (4.1)].Guanylate Cyclase (GC) StimulatorsPhysicians should discuss with patients the contraindication of sildenafil tablets with use of guanylate cyclase stimulators such as riociguat [see Contraindications (4.3)].Concomitant Use with Drugs Which Lower Blood PressurePhysicians should advise patients of the potential for sildenafil tablets to augment the blood pressure lowering effect of alpha-blockers and anti-hypertensive medications.

Sign Up Easily

Concomitant administration of sildenafil tablets and an alphablocker may lead to symptomatic hypotension in some patients. Therefore, when sildenafil tablets is co-administered with alpha-blockers, patients should be stable on alpha-blocker therapy prior to initiating sildenafil tablets treatment and sildenafil tablets should be initiated at the lowest dose [see Warnings and Precautions (5.5)].Cardiovascular ConsiderationsPhysicians should discuss with patients the potential cardiac risk of sexual activity in patients with preexisting cardiovascular risk factors. Patients who experience symptoms (e.g., angina pectoris, dizziness, nausea) upon initiation of sexual activity should be advised to refrain from further activity and should discuss the episode with their physician [see Warnings and Precautions (5.1)].Sudden Loss of VisionPhysicians should advise patients to stop use of all PDE5 inhibitors, including sildenafil tablets, and seek medical attention in the event of a sudden loss of vision in one or both eyes. Such an event may be a sign of non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including possible permanent loss of vision, that has been reported rarely post-marketing in temporal association with the use of all PDE5 inhibitors. Physicians should discuss with patients the increased risk of NAION in individuals who have already experienced NAION in one eye.

20. Why choose Taj Pharma?

Physicians should also discuss with patients the increased risk of NAION among the general population in patients with a “crowded” optic disc, although evidence is insufficient to support screening of prospective users of PDE5 inhibitor, including sildenafil tablets, for this uncommon condition [see Warnings and Precautions (5.3) and Adverse Reactions (6.2)].Sudden Hearing LossPhysicians should advise patients to stop taking PDE5 inhibitors, including sildenafil tablets, and seek prompt medical attention in the event of sudden decrease or loss of hearing. These events, which may be accompanied by tinnitus and dizziness, have been reported in temporal association to the intake of PDE5 inhibitors, including sildenafil tablets. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors [see Warnings and Precautions (5.4) and Adverse Reactions (6.2)].PriapismPhysicians should warn patients that prolonged erections greater than 4 hours and priapism (painful erections greater than 6 hours in duration) have been reported infrequently since market approval of sildenafil tablets. If priapism is not treated immediately, penile tissue damage and permanent loss of potency may result [see Warnings and Precautions (5.2)].Avoid Use with other PDE5 InhibitorsPhysicians should inform patients not to take sildenafil tablets with other PDE5 inhibitors including REVATIO or other pulmonary arterial hypertension (PAH) treatments containing sildenafil. Sildenafil is also marketed as REVATIO for the treatment of PAH. Therefore, when sildenafil tablets is co-administered with alpha-blockers, patients should be stable on alpha-blocker therapy prior to initiating sildenafil tablets treatment and sildenafil tablets should be initiated at the lowest dose [see Warnings and Precautions (5.5)].Cardiovascular ConsiderationsPhysicians should discuss with patients the potential cardiac risk of sexual activity in patients with preexisting cardiovascular risk factors. Patients who experience symptoms (e.g., angina pectoris, dizziness, nausea) upon initiation of sexual activity should be advised to refrain from further activity and should discuss the episode with their physician [see Warnings and Precautions (5.1)].Sudden Loss of VisionPhysicians should advise patients to stop use of all PDE5 inhibitors, including sildenafil tablets, and seek medical attention in the event of a sudden loss of vision in one or both eyes. Such an event may be a sign of non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including possible permanent loss of vision, that has been reported rarely post-marketing in temporal association with the use of all PDE5 inhibitors. Physicians should discuss with patients the increased risk of NAION in individuals who have already experienced NAION in one eye. Physicians should also discuss with patients the increased risk of NAION among the general population in patients with a “crowded” optic disc, although evidence is insufficient to support screening of prospective users of PDE5 inhibitor, including sildenafil tablets, for this uncommon condition [see Warnings and Precautions (5.3) and Adverse Reactions (6.2)].Sudden Hearing LossPhysicians should advise patients to stop taking PDE5 inhibitors, including sildenafil tablets, and seek prompt medical attention in the event of sudden decrease or loss of hearing. These events, which may be accompanied by tinnitus and dizziness, have been reported in temporal association to the intake of PDE5 inhibitors, including sildenafil tablets.

The cost of sildenafil 50 mg in India varies depending on the brand.
Genuine sildenafil is manufactured by reputable companies like Pfizer.
It's important to buy from authorized pharmacies to avoid counterfeit products.
Sildenafil 50 mg is often combined with other medications for enhanced effect.
Overuse or misuse can lead to serious health issues like low blood pressure.
The medication is not suitable for individuals on nitrate medications.
Sildenafil 50 mg can interact with alcohol, reducing its effectiveness.
People with heart problems should consult a doctor before use.
Keeping the medication away from children is essential to prevent accidental ingestion.

It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors [see Warnings and Precautions (5.4) and Adverse Reactions (6.2)].PriapismPhysicians should warn patients that prolonged erections greater than 4 hours and priapism (painful erections greater than 6 hours in duration) have been reported infrequently since market approval of sildenafil tablets. If priapism is not treated immediately, penile tissue damage and permanent loss of potency may result [see Warnings and Precautions (5.2)].Avoid Use with other PDE5 InhibitorsPhysicians should inform patients not to take sildenafil tablets with other PDE5 inhibitors including REVATIO or other pulmonary arterial hypertension (PAH) treatments containing sildenafil. Sildenafil is also marketed as REVATIO for the treatment of PAH.

Side Effects?

Sildenafil 50 mg can help men regain confidence with effective treatment.
It is essential to follow the prescribed dosage to minimize side effects.
The medication is usually well tolerated, but side effects should be monitored.
It is not recommended to use sildenafil for recreational purposes.
Consult a doctor immediately if an erection lasts longer than 4 hours.
Sildenafil may be less effective or unsafe in certain health conditions.
The drug is not a stimulant but enhances response to sexual arousal.
Proper timing of dosage improves the chances of successful intercourse.
Education about proper use is crucial for safe medication management.

Counseling of patients about the protective measures necessary to guard against sexually transmitted diseases, including the Human Immunodeficiency Virus (HIV), may be considered [see Warnings and Precautions (5.9)].Manufactured for :Macleods Pharma USA, Inc.Princeton, NJ 08540Manufactured by:Macleods Pharmaceuticals Ltd.At Oxalis LabsBaddi, Himachal Pradesh, INDIARevised: July 2025 Advise the patient to read the FDA-approved patient labeling (Patient Information) Physicians should discuss with patients the contraindication of sildenafil tablets with regular and/or intermittent use of nitric oxide donors, such as organic nitrates or organic nitrites in any form [see Contraindications (4.1)].

Sildenafil Pricing in India

1. State-of-the-Art Manufacturing Facilities

On a global improvement question, 57% of sildenafil patients reported improved erections versus 10% on placebo. Diary data indicated that on sildenafil, 48% of intercourse attempts were successful versus 12% on placebo.One randomized, double-blind, placebo-controlled, crossover, flexible-dose (up to 100 mg) study of patients with erectile dysfunction resulting from spinal cord injury (n=178) was conducted. The changes from baseline in scoring on the two end point questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) were highly statistically significantly in favor of sildenafil. On a global improvement question, 83% of patients reported improved erections on sildenafil versus 12% on placebo. Diary data indicated that on sildenafil, 59% of attempts at sexual intercourse were successful compared to 13% on placebo.Across all trials, sildenafil improved the erections of 43% of radical prostatectomy patients compared to 15% on placebo.Subgroup analyses of responses to a global improvement question in patients with psychogenic etiology in two fixed-dose studies (total n=179) and two titration studies (total n=149) showed 84% of sildenafil patients reported improvement in erections compared with 26% of placebo.

Viagra Tablets

Diary data in two of the studies (n=178) showed rates of successful intercourse per attempt of 70% for sildenafil and 29% for placebo.Efficacy Results in Subpopulations in Controlled Clinical StudiesA review of population subgroups demonstrated efficacy regardless of baseline severity, etiology, race and age.Sildenafil was effective in a broad range of ED patients, including those with a history of coronary artery disease, hypertension, other cardiac disease, peripheral vascular disease, diabetes mellitus, depression, coronary artery bypass graft (CABG), radical prostatectomy, transurethral resection of the prostate (TURP) and spinal cord injury, and in patients taking antidepressants/antipsychotics and anti-hypertensives/diuretics. In clinical studies, sildenafil was assessed for its effect on the ability of men with erectile dysfunction (ED) to engage in sexual activity and in many cases specifically on the ability to achieve and maintain an erection sufficient for satisfactory sexual activity. The studies that established benefit demonstrated improvements in success rates for sexual intercourse compared with placebo. Effect of Sildenafil tablets and Placebo on Maintenance of sildenafil generic Erection by Baseline Score. Percentage of Patients Reporting an Improvement in Erections.

50mg Sildenafil Citrate Tablet